Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Ishikazu Mizuno"'
Autor:
Takeshi Araki, Shinya Ohata, Kohei Okamoto, Kazuhide Morimoto, Mana Hiraishi, Shinichiro Yamada, Ishikazu Mizuno, Takeshi Sugimoto
Publikováno v:
Case Reports in Hematology, Vol 2019 (2019)
A 67-year-old male, with a known diagnosis of myelodysplastic syndromes with multilineage dysplasia (MDS-MLD) was admitted to our hospital with a primary complaint of subcutaneous bleeding in his left thigh. Laboratory data showed anaemia and prolong
Externí odkaz:
https://doaj.org/article/499220e94aee4c60bd2ef01657f9c97d
Autor:
Kimimori Kamijo, Yoshimitsu Shimomura, Akihito Shinohara, Shohei Mizuno, Minoru Kanaya, Yoshiaki Usui, Sung-Won Kim, Takahide Ara, Ishikazu Mizuno, Takuro Kuriyama, Hideyuki Nakazawa, Ken-ichi Matsuoka, Shigeru Kusumoto, Nobuo Maseki, Masaki Yamaguchi, Takashi Ashida, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Eisei Kondo
Publikováno v:
Annals of Hematology. 102:651-661
Allogeneic hematopoietic cell transplantation (HCT) offers a possible cure for patients with relapsed and refractory non-Hodgkin lymphoma (NHL) through potentially beneficial graft versus lymphoma effects. However, allogeneic HCT is associated with h
Autor:
Masayuki Hino, Yukari Umemoto, Yosuke Makuuchi, Hiroshi Okamura, Hideo Koh, Keiko Hagiyama, Katsumi Orihara, Takafumi Nakao, Masaya Okada, Nobuhiko Uoshima, Mitsuru Itoh, Kimikazu Yakushijin, Akinori Nishikawa, Jun Ishikawa, Ishikazu Mizuno, Takayuki Ishikawa, Takahiro Fukuda
Publikováno v:
Japanese Journal of Transplantation and Cellular Therapy. 11:114-121
Autor:
Miyako Takahashi, Katsuhiro Shono, Takahiko Sato, Shin ichiro Fujiwara, Akio Kohno, Takuhiro Yamaguchi, Yukari Umemoto, Masatsugu Tanaka, Saiko Kurosawa, Ayako Mori, Tadakazu Kondo, Seiko Kato, Tomoko Matsuura, Satoshi Yoshioka, Takehiko Mori, Yuta Katayama, Shinichiro Machida, Ishikazu Mizuno, Hideki Goto, Takahiro Fukuda
Publikováno v:
Journal of Cancer Survivorship. 16:1004-1015
To characterize the issues regarding work and employment specific to allogeneic hematopoietic cell transplantation (allo-HCT) survivors, we conducted a nationwide cross-sectional questionnaire survey. We targeted allo-HCT survivors employed at diagno
Autor:
Masaki Ri, Shinsuke Iida, Naoki Hosen, Koichiro Minauchi, Shuji Ozaki, Shigeo Fuji, Shingen Nakamura, Hiroyuki Takamatsu, Ishikazu Mizuno, Yoichi Imai, Ichiro Hanamura, Hirohisa Nakamae, Eiju Negoro, Hiroshi Handa, Satoshi Yoshihara, Kenshi Suzuki, Yawara Kawano, Masahiro Kizaki, Rikio Suzuki, Junya Kuroda, Noriko Nishimura, Yasuyuki Nagata, Yoshimitsu Shimomura, Nobuhiko Uoshima, Hiroshi Kosugi, Hiroshi Gomyo
Publikováno v:
International Journal of Hematology. 114:3-7
Multiple myeloma (MM) is still extremely difficult to cure, and new therapeutic drugs are needed. We recently found that integrin β7 is constitutively activated in MM cells, and chimeric antigen receptor (CAR) T cells targeting activated integrin β
Autor:
Kimimori Kamijo, Yoshimitsu Shimomura, Sung-Won Kim, Takahide Ara, Jun Ishikawa, Tetsuya Eto, Nobuhiro Hiramoto, Ishikazu Mizuno, Shigeru Kusumoto, Yasunori Ueda, Ken-ichi Matsuoka, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Eisei Kondo
Publikováno v:
Blood. 140:2393-2394
Autor:
Dai Maruyama, Shinsuke Iida, Ryunosuke Machida, Shigeru Kusumoto, Noriko Fukuhara, Nobuhiko Yamauchi, Kana Miyazaki, Makoto Yoshimitsu, Junya Kuroda, Norifumi Tsukamoto, Hideki Tsujimura, Kensuke Usuki, Takahiro Yamauchi, Takahiko Utsumi, Ishikazu Mizuno, Yasushi Takamatsu, Yasuyuki Nagata, Shuichi Ota, Eiichi Ohtsuka, Ichiro Hanamura, Yasuhiro Suzuki, Shinichiro Yoshida, Satoshi Yamasaki, Youko Suehiro, Yutaro Kamiyama, Suguru Fukuhara, Kunihiro Tsukasaki, Hirokazu Nagai
Publikováno v:
Cancer science. 113(9)
Autor:
Hirokazu Nagai, Gakuto Ogawa, Shinsuke Iida, Ishikazu Mizuno, Eiichi Ohtsuka, Takahiro Yamauchi, Dai Maruyama, Noriko Fukuhara, Koichiro Minauchi, Junya Kuroda, Shinichiro Yoshida, Youko Suehiro, Hideki Tsujimura, Yasuyuki Nagata, Kunihiro Tsukasaki, Satoshi Yamasaki, Sachiko Seo, Kana Miyazaki, Makoto Yoshimitsu, Akira Hangaishi, Norifumi Tsukamoto, Takahiko Utsumi, Yutaro Kamiyama, Ichiro Hanamura, Yasushi Takamatsu
Publikováno v:
British Journal of Haematology
Summary We conducted a randomised phase II study to determine the optimal dose and schedule of melphalan, prednisone, and bortezomib (MPB) (jRCTs031180097). Transplant‐ineligible untreated multiple myeloma patients were randomised to Arm A (twice w
Autor:
Hidetsugu Saito, Satoshi Hashino, Yuko Ishihara, Masashi Mizokami, Kazuaki Inoue, Makoto Onizuka, Masahiro Onozawa, Kazuhiko Kakihana, Masaya Sugiyama, Koji Nishikawa, Ishikazu Mizuno, Yasushi Onishi, Masahide Yamamoto, Shigeru Kusumoto, Hisashi Sakamaki, Noriko Doki, Tetsuya Ishikawa, Kazuteru Ohashi, Kazuhiro Takahashi, Tatsuya Kanto, Yoshinobu Kanda, Sung Kwan Bae, Kiminori Kimura
Publikováno v:
Bone Marrow Transplantation
Hepatitis B virus (HBV) reactivation reportedly occurs frequently after hematopoietic stem cell transplantation (HSCT) in resolved HBV-infected patients. Here, 50 patients with resolved HBV infections and scheduled to undergo HSCT were enrolled; all
Autor:
Jin Takeuchi, Keiko Fukunaga, Takahiro Fukuda, Hiroki Yamaguchi, Heiwa Kanamori, Junya Kanda, Shunsuke Yui, Haruko Tashiro, Takuhiro Yamaguchi, Shingo Yano, Junji Tomiyama, Kensuke Usuki, Nobuhiko Uoshima, Koiti Inokuchi, Saiko Kurosawa, Ishikazu Mizuno, Shigeru Chiba, Hiroshi Okamura, Takero Shindo, Masamitsu Yanada
Publikováno v:
International journal of hematology. 112(2)
We evaluated the impact of FLT3-ITD, NPM1 mutations, and double mutant CEBPa (dmCEBPa) on overall survival (OS) after relapse in patients with cytogenetically intermediate-risk acute myeloid leukemia (AML) who were treated with chemotherapy alone in